期刊文献+

柱前衍生高效液相色谱法测定人血浆中白消安的浓度 被引量:15

Determination of busulfan in human plasma by HPLC with pre-colum derivatization
下载PDF
导出
摘要 目的:建立测定人血浆中白消安浓度的高效液相色谱法。方法:血浆样品经衍生化处理后,以甲醇-水(74:26)为流动相,流速0.9mL·min^-1,选用Nova Pak C18色谱柱(3.9mm×150mm,4μm),在280nm波长下进行检测。结果:白消安血浆质量浓度的线性范围为0.050~3.20mg·L^-1,以加权最小二乘法运算得到回归方程为Y=4.575X-37.04(r=0.9993,n=9),方法回收率(100.6±1.6)%(99.66%~102.4%),血浆萃取回收率(83.6±2.4)%(81.70%~86.35%),日内和日间RSD均小于15%。检测限为0.6ng,最低血浆检测质量浓度为0.030mg·L^-1。结论:该方法准确、灵敏,适用于白消安血浆浓度测定及其药动学研究。 ORJECTIVE To develop an HPLC assay for determination of busulfan concentration in human plasma. METHODS Plasma samples were prepared by derivatization with sodium diethyldithiocarbamate(DDTC) and extracted with ethyl acetate,the extract was dried under nitrogen and reconstituted with methanol prior to HPLC determination. Chromatography was accomplished using a NovaPak C18 analytical colum (4μm,3. 9 mm× 150 mm) and mobile phase of methanol-water(74:26) at a flow rate of 0. 9 mL·min^-1 with UV detection at 280 nm. RESULTS Calibration curves were linear from 0. 05 to 3. 20 mg·L^-1 (r = 0. 999 3, n = 9), the recovery of method was ( 100. 6 ± 1.6) % (99. 66% - 102. 4% ), and the mean extraction yield for busulfan in plasma was (83.6 ± 2. 4) % (81.70% - 86. 35%). The RSDs of intra- and inter-day were lower than 11.20% and 14. 99%, respectively. The limit of detection was 0. 030 mg·L^-1 (signal-to noise ratio of 6). CONCLUSION The method is sensitive and accurate for the determination of busulfan concentration in human plasma. It is suitable for the pharmacokinetics study of busulfan.
机构地区 安徽省立医院
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第4期458-461,共4页 Chinese Journal of Hospital Pharmacy
基金 2007年安徽高校省级自然科学研究项目(编号KJ2007B317ZC)
关键词 白消安 高效液相色谱法 血药浓度 busulfan HPLC plasma drug concentration
  • 相关文献

参考文献12

  • 1朱康儿,徐扬,钟隽,陈盛亭,曾慧兰.BU-CTX_2预处理方案异基因造血干细胞移植治疗白血病60例[J].中华血液学杂志,2002,23(7):349-352. 被引量:8
  • 2郑春梅,张玲,冯四洲,赵春华.马利兰在造血干细胞移植预处理方案中的使用及研究进展[J].国外医学(输血及血液学分册),2003,26(6):513-516. 被引量:12
  • 3Hassan BM,Ljungman P,Bolme P,et al.Busulfan bioavailability[J].Blood,1994,84(7):2144-2150. 被引量:1
  • 4McCune JS,Gibbs JP,Slattery JT.Plasma concentration monitoring of busulfan.does it improve clinical outcome?[J].Clin Pharmacokinet,2000,39(2):155-164. 被引量:1
  • 5Chen TL,Grochow LB,Hurowitz LA,et al.Determination of busulfan in human plasma by gas chromatography with electron-capture detection[J].J Chromatogr,1988,425:303-309. 被引量:1
  • 6Rifai N,Sakamoto M,Lafi M,et al.Measurement of plasma busulfan concentration by high-performance liquid chromatography with ultraviolet detection[J].Ther Drug Monit,1997,19:169-174. 被引量:1
  • 7Henner WD,Furlong EA,Flaherty MD,et al.Measurement of busulfan in plasma by high-performance liquid chromatography[J].J Chromatogr B,1987,416;426-432. 被引量:1
  • 8Dos Reis FO,Vianna-Jorge R,Suarez-Kurtz G,et al.Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry[J].Rapid Commun Mass Spectrom,2005,19:1666-1674. 被引量:1
  • 9Kellogg MD,Law T,Sakamoto M,et al.Tandem mass spectrometry method for the quantification of serum busulfan[J].Ther Drug Monit,2005,27(5):625-629. 被引量:1
  • 10Auh M,Stachel D,Kuhlen M,et al.Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children:validation of liquid chromatography tandem mass spectrometry method[J].Clin Pharmacokinet,2006,45 (3):305-316. 被引量:1

二级参考文献5

  • 1Camara R,Granados E,Gil JJ,et al.Bone marrow transplantation in acute lymphoblastic leukemia (ALL): comparison of busulfan vs total body irradiation (TBI) as conditioning[].Bone Marrow Transplantation.1998 被引量:1
  • 2Copelan EA,Biggs JC,Szer J,et al.Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BU-CY2 )[].Seminars in Oncology.1993 被引量:1
  • 3Bueltzingsloewen AV,Belanger R,Perreault C,et al.Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etopside conditioning regimen for patients with acute lymphoblastic leukemia[].British Journal of Haematology.1993 被引量:1
  • 4Han P,McDonald T,Mangos H,et al.Immune escape mechanisms of acute lymphoblastic leukemia ( ALL) cells and a potential countering role for dentritic-like leukemia cells[].Blood.2000 被引量:1
  • 5Cornelisssen JJ,Carston M,Kollman C,et al.Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome[].Blood.2001 被引量:1

共引文献18

同被引文献126

  • 1孙自敏,王祖贻,刘会兰,刘欣,朱薇波,韩永胜,杨会志,潘理明,吴树农,吴竟生.异基因造血干细胞移植治疗恶性血液病[J].临床血液学杂志,2004,17(5):257-260. 被引量:5
  • 2董莉,裘一兰,钱小平,孙利.气相色谱法测定白消安片中白消安的含量[J].药物分析杂志,2005,25(3):292-293. 被引量:3
  • 3肖毅,张义成,张东华,黄亮,周剑峰,孙汉英,刘文励.采用静脉注射白消安预处理方案的异基因造血干细胞移植治疗恶性血液病一例[J].中华器官移植杂志,2006,27(11):695-697. 被引量:2
  • 4Fisher L, VL,Barnes YJ,Nuss SL. Pretransplant conditioning in adults and children:Dose assurance with intravenous busulfan[J ]. Oncol Nurs Forum. 2006,33 (2) : E36-E43. 被引量:1
  • 5Iravani M,Evazi MR,Mousavi SA,etal. Fludarabine and busul fan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients [J]. Bone Marrow Transplant,2007,40:105-110. 被引量:1
  • 6Chae YS, Sohn SK, Kim JG, et al. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation:comparison with BuCy2[J]. Bone Marrow Transplan t, 2007,40: 541-547. 被引量:1
  • 7Van den Bongard HJG. Mathot RAA, Beijnen J H, et al. Pharmacokinetically guided administration of chemotherapeutic agents[J]. Clin Pharmacokinet, 2000,39 (5) : 345-367. 被引量:1
  • 8McCune J S, Gibbs JP, Slattery JT. Plasma concentration monitoring of busulfan:does it improve clinical outcome? [J]. Clin Pharmacokinet, 2000, 39(2) : 155-164. 被引量:1
  • 9McCune JS, Gooley T, Gibbs JP, et al. Busulfan concentration and graft rejection in pediatric patients undergoing hematopoieric stem cell transplantation[J]. Bone Marrow Transplant, 2002,30:167- 173. 被引量:1
  • 10Henner WD, Furlong EA, Flaherty MD, et al. Measurement of busulfan in plasma by high performance liquid chromatography[J]. J Chromatogr B,1987,416:426-432. 被引量:1

引证文献15

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部